HBV
Hepatitis B virus
HBV (Hepatitis B virus), abbreviated HBV, is a species of the genus Orthohepadnavirus, which is likewise a part of the Hepadnaviridae family of viruses. HBV causes the disease hepatitis B. The hepatitis B virus is classified as the type species of the Orthohepadnavirus, which contains three other species: the Ground squirrel hepatitis virus, Woodchuck hepatitis virus, and theWoolly monkey hepatitis B virus. The genus is classified as part of the Hepadnaviridae family. HBV is divided into four major serotypes (adr, adw, ayr, ayw) based on antigenic epitopes present on its envelope proteins, and into eight genotypes (A–H) according to overall nucleotide sequence variation of the genome. The genotypes have a distinct geographical distribution and are used in tracing the evolution and transmission of the virus. Differences between genotypes affect the disease severity, course and likelihood of complications, and response to treatment and possibly vaccination.
All Product Categories
-
HBV Related Products (384)
Related Products (384)
-
Antibodies (2)
-
Anti-GOLM1 Antibody
0 ImagesCat. No.: HY-P990421Anti-GOLM1 Antibody is a CHO-expressed human antibody that targets GOLM1. The Anti-GOLM1 Antibody is composed of a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-GOLM1 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
-
HBV Seq1 aa:18-27
0 ImagesCat. No.: HY-P4050CAS No.: 147820-47-1
-
Nicotinamide (GMP)
0 ImagesNicotinamide (GMP) (Niacinamide (GMP)) is the GMP level of Nicotinamide (HY-B0150). GMP guidelines are used to produce Nicotinamide (GMP). GMP small molecules works appropriately as an auxiliary reagent for cell research manufacture. Nicotinamide is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide also inhibits SIRT1. Nicotinamide increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibits tumor growth and improves survival. Nicotinamide also has anti-HBV activity.
-
HBV/HDV-IN-4 hydrochloride
0 ImagesCat. No.: HY-163581ACAS No.: 3034059-40-7
-
GLPG3808
0 ImagesCat. No.: HY-181347CAS No.: 2346450-55-1
-
HBV/HDV-IN-1
0 ImagesCat. No.: HY-161604CAS No.: 3034161-55-9HBV/HDV-IN-1 (Compd 122) is a HBV, HDV and PD-1/PD-L1 inhibitor, with EC50 values of 8 nM for T cell activation and 35 nM for PD-L1 internalization.
-
Pevifoscorvir
0 ImagesCat. No.: HY-169993ACAS No.: 2495324-71-3Synonyms: ALG-000184 free acidPevifoscorvir (ALG-000184 (free acid)) is an orally active inhibitor of hepatitis B virus (HBV), and it is also a prodrug of ALG-001075 (HY-177022). Pevifoscorvir can inhibit the production of HBV DNA in liver cells. Pevifoscorvir can be used in the research of chronic hepatitis B.
-
AB-452
0 ImagesCat. No.: HY-163149CAS No.: 2226178-35-2
-
Daplusiran sodium
0 ImagesCat. No.: HY-177625A
-
Isochlorogenic acid A (Standard)
0 ImagesSynonyms: 3,5-Dicaffeoylquinic acid (Standard); 3,5-CQA (Standard)Isochlorogenic acid A (Standard) is the analytical standard of Isochlorogenic acid A. This product is intended for research and analytical applications. Isochlorogenic acid A (3,5-Dicaffeoylquinic acid) is a natural phenolic acid with anti-mutagenicity, anti-HBV, anti-HIV, anti-oxidant, anti-bacterial, and anti-inflammatoryy activities.
-
HBeAg ligand 1
0 ImagesCat. No.: HY-174857CAS No.: 2361022-13-9
-
Xentry
0 ImagesCat. No.: HY-P11083CAS No.: 1352335-71-7Xentry is a cell-penetrating peptide (CCP) consisting of only 7 amino acids of hepatitis B virus: LCLRPVG. Xentry-linked anti-B-raf antibodies and siRNAs demonstrates the capability to kill B-raf-dependent melanoma cells. Xentry alone or conjugated to β-galactosidase leads to its delivery to most tissues in mice, except circulating blood cells. Xentry can be used for the delivery of large molecules (antibodies, siRNA, enzymes) .
-
Apigenin-4'-α-L-rhamnoside
0 ImagesCat. No.: HY-N2882CAS No.: 133538-77-9
-
Rapavir
0 ImagesCat. No.: HY-172835Synonyms: JH-B10Rapavir (JH-B10) is a selective and potent sodium taurocholate cotransporting polypeptide (NTCP) inhibitor with an IC50 value of 1.8 nM for the uptake of taurocholic acid-d4 (TCA-d4). Rapavir exerts antiviral activity by directly binding to NTCP and blocking the entry of the virus into cells during the HBV infection phase. Rapavir is promising for research of HBV infections.
